FI901237A0 - Ws7622a-, b-, c- och d-substanser, deras derivat, foerfarande foer deras framstaellning och deras anvaendning. - Google Patents

Ws7622a-, b-, c- och d-substanser, deras derivat, foerfarande foer deras framstaellning och deras anvaendning.

Info

Publication number
FI901237A0
FI901237A0 FI901237A FI901237A FI901237A0 FI 901237 A0 FI901237 A0 FI 901237A0 FI 901237 A FI901237 A FI 901237A FI 901237 A FI901237 A FI 901237A FI 901237 A0 FI901237 A0 FI 901237A0
Authority
FI
Finland
Prior art keywords
deras
och
ws7622a
substanser
derivat
Prior art date
Application number
FI901237A
Other languages
English (en)
Inventor
Hiroshi Hatanaka
Masami Ezaki
Eisaku Tsujii
Masanori Okamoto
Nobuharu Shigematsu
Masakuni Okuhara
Shigehiro Takase
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898905817A external-priority patent/GB8905817D0/en
Priority claimed from GB898920485A external-priority patent/GB8920485D0/en
Priority claimed from GB898921078A external-priority patent/GB8921078D0/en
Priority claimed from GB898922164A external-priority patent/GB8922164D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of FI901237A0 publication Critical patent/FI901237A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI901237A 1989-03-14 1990-03-13 Ws7622a-, b-, c- och d-substanser, deras derivat, foerfarande foer deras framstaellning och deras anvaendning. FI901237A0 (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB898905817A GB8905817D0 (en) 1989-03-14 1989-03-14 Fr901277 substance,process for preparation thereof and use thereof
GB898920485A GB8920485D0 (en) 1989-09-11 1989-09-11 Fr901278 substance,process for preparation thereof and use thereof
GB898921078A GB8921078D0 (en) 1989-09-18 1989-09-18 Fr901277 substance,process for preparation thereof and use thereof
GB898922164A GB8922164D0 (en) 1989-10-02 1989-10-02 Fr 901277 substance,derivatives thereof,processes for preparation thereof and use thereof

Publications (1)

Publication Number Publication Date
FI901237A0 true FI901237A0 (fi) 1990-03-13

Family

ID=27450289

Family Applications (1)

Application Number Title Priority Date Filing Date
FI901237A FI901237A0 (fi) 1989-03-14 1990-03-13 Ws7622a-, b-, c- och d-substanser, deras derivat, foerfarande foer deras framstaellning och deras anvaendning.

Country Status (17)

Country Link
US (2) US5021240A (fi)
EP (1) EP0387712B1 (fi)
JP (1) JP2811881B2 (fi)
KR (1) KR900014600A (fi)
CN (1) CN1046938A (fi)
AT (1) ATE123529T1 (fi)
AU (1) AU628938B2 (fi)
CA (1) CA2012074A1 (fi)
DE (1) DE69019848T2 (fi)
DK (1) DK0387712T3 (fi)
ES (1) ES2072934T3 (fi)
FI (1) FI901237A0 (fi)
HU (1) HUT56395A (fi)
IL (1) IL93548A (fi)
NO (1) NO901160L (fi)
PH (1) PH27266A (fi)
PT (1) PT93427A (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU625292B2 (en) * 1988-09-09 1992-07-09 Czechoslovak Academy Of Sciences Elastase inhibiting polymers and methods
GB9014546D0 (en) * 1990-06-29 1990-08-22 Fujisawa Pharmaceutical Co Ws7622a mono-or di-sulfate,process for preparation thereof and use thereof
EP0519354B1 (en) * 1991-06-18 1997-12-10 Fujisawa Pharmaceutical Co., Ltd. A prophylactic/therapeutic composition containing WS7622A for preventing or treating disseminated intravascular coagulation, chronic respiratory tract infectious disease or chronic bronchitis
JP2002161051A (ja) * 1996-12-24 2002-06-04 Fujisawa Pharmaceut Co Ltd 脳虚血性疾患等の治療剤
EP1057491B1 (en) * 1998-02-24 2013-06-19 Astellas Pharma Inc. Preventives/remedies for skin aging
CN1407902A (zh) * 1999-10-12 2003-04-02 藤泽药品工业株式会社 难治性创伤的治疗剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD84898A (fi) *
DE1132925B (de) * 1960-02-19 1962-07-12 Bayer Ag Loesungsvermittler fuer wasserschwerloesliche organische Verbindungen
US4537770A (en) * 1982-03-24 1985-08-27 Eli Lilly And Company A41030 antibiotics
US4695545A (en) * 1982-03-24 1987-09-22 Eli Lilly And Company Culture and process for producing A41030 antibiotics
US4596822A (en) * 1984-08-20 1986-06-24 Georgia Tech Research Corporation Heterocyclic inhibitors of serine proteases
GB8425685D0 (en) * 1984-10-11 1984-11-14 Lepetit Spa Antibiotic a 40926 complex

Also Published As

Publication number Publication date
ES2072934T3 (es) 1995-08-01
EP0387712A1 (en) 1990-09-19
HUT56395A (en) 1991-08-28
JPH03218387A (ja) 1991-09-25
NO901160D0 (no) 1990-03-13
CA2012074A1 (en) 1990-09-14
EP0387712B1 (en) 1995-06-07
DE69019848D1 (de) 1995-07-13
IL93548A (en) 1994-10-07
KR900014600A (ko) 1990-10-24
JP2811881B2 (ja) 1998-10-15
PH27266A (en) 1993-05-04
DK0387712T3 (da) 1995-08-14
CN1046938A (zh) 1990-11-14
US5167958A (en) 1992-12-01
IL93548A0 (en) 1990-11-29
US5021240A (en) 1991-06-04
ATE123529T1 (de) 1995-06-15
HU901427D0 (en) 1990-06-28
DE69019848T2 (de) 1995-12-07
NO901160L (no) 1990-09-17
PT93427A (pt) 1990-11-07
AU628938B2 (en) 1992-09-24
AU5116890A (en) 1990-09-20

Similar Documents

Publication Publication Date Title
FI954246A0 (fi) Uusia A83543-yhdisteitä ja menetelmä niiden valmistamiseksi
FI891581A (fi) Peptidderivat.
FI901237A0 (fi) Ws7622a-, b-, c- och d-substanser, deras derivat, foerfarande foer deras framstaellning och deras anvaendning.
DE68916659D1 (de) WS-9326 A, WS-9326B und deren Derivate.
FI912914A (fi) Ws622a mono- eller di-sulfat, foerfarande foer dess framstaellning och dess anvaendning.
DE68918071D1 (de) Antibiotikum A80915 und Verfahren zu seiner Herstellung.
IL90575A (en) Ab-011 antibiotics, their production and compositions containing them
BG95629A (en) Derivatives of 10, 11, 12, 13 - tetrahytdrodesmicozine, method for preparing them, and their use as pharmaceutical preparations

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: FUJISAWA PHARMACEUTICAL CO., LTD.